Improve your site's relationship with monitors

January 2008
Clinical Trials Administrator;Jan2008, Vol. 6 Issue 1, p10
The article offers advice on how to improve the relationship between clinical trial professionals and clinical research monitors. A good relationship between both parties is characterized by having clear communication and an understanding of expectations and goals. According to Raleigh Neurology Associations research director Jane K. Downs, RN, it is important for the professionals and the monitors to compromise and look at things from both perspectives.


Related Articles

  • Independent Nurse: Review of guidance for hypertension.  // GP: General Practitioner;9/9/2005, p99 

    The article reports that NICE and the British Hypertension Society are to undertake a collaborative review of their hypertension guidance in the light of new clinical trial data.

  • Clinical Trials Summit. Herschel, Michael // Applied Clinical Trials;Dec2005, Vol. 14 Issue 12, p74 

    The article provides information on the 6th Annual Clinical Trials Summit that took place from 24-25 January, 2006 in Munich, Germany. The summit discussed on the topic of efficiency of developing drugs. According to the author, classical way of developing drugs in phases I, II, and Ill, despite...

  • Systematic reviews in cystic fibrosis. Smyth, Rosalind L.; Cheng, Katharine; Motley, Jill // Journal of the Royal Society of Medicine (Supplement);Feb1998, Vol. 91 Issue 34, p19 

    The article discusses the importance of systematic reviews of randomized controlled trials and the steps for conducting a systematic review. Randomized controlled trial (RCT) has generally been accepted as the most efficient method to evaluate treatment. The strengths and limitations of RCT are...

  • Research organizations closely analyze sponsors and studies for a good match.  // Clinical Trials Administrator;Dec2009, Vol. 7 Issue 12, p133 

    The article offers suggestions to clinical research organizations for establishing or improving protocol feasibility analysis processes in order to reduce clinical trial problems and failures. Emphasis is given on the need to find out more about the protocol and the sponsor and to ask for...

  • Attention to details when improving recruitment.  // Clinical Trials Administrator;May2007, Vol. 5 Issue 5, p57 

    The article discusses the importance of paying attention to details when choosing subjects for clinical trials. According to Dr. Bryce Bartruff of Sanofi-Aventis in Malvern, Pennsylvania, pharmaceutical companies or clinical research organizations should have a strategy when recruiting subjects...

  • The Cochrane Collaboration: catching up with the evidence.  // Bulletin of the World Health Organization;1994, Vol. 72 Issue 4, p675 

    The article offers information on the Cochrane Collaboration. The collaboration was developed by a network of individuals who has taken up the challenge of epidemiologist Archie Cochrane to establish randomized controlled trial reviews in health care. It is comprised of a series of collaborative...

  • A Consensus for Accreditation. Speers, Marjorie // Applied Clinical Trials;May2006, Vol. 15 Issue 5, p78 

    The article comments on the issue of accreditation in clinical trials. In recent times, the Association for the Accreditation of Human Research Protection Programs has seen an increase in demand by research organizations and sponsors. Accreditation helps to build trust and serves as an honor for...

  • Clinical Trials in Surgery: The Role of the American College of Surgeons Oncology Group. You, Y. Nancy; Wells, Samuel A. // World Journal of Surgery;Jul2006, Vol. 30 Issue 7, p1147 

    The article focuses on the the contribution of the American College of Surgeons Oncology Group(ACOSOG) in developing new clinical trials for the treatment of cancer. ACOSOG plays a role in educating surgeons and other trial participants as well as improving trial participation and leadership...

  • Ethical disclosure. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;3/3/2009, Vol. 180 Issue 5, p505 

    The article reports on the ethical disclosure guidelines for physicians and scientists developed by the Association for Medical Ethics in Canada. The guidelines require physicians and scientists to make financial disclosure for trials that exceed $500 every year as well as should avoid financial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics